Concepedia

Eric J. Bonventre

EJ

Statistics

Publications

3

Citations

164

H-Index

3

Active since

2006

Affiliations

Cubist Pharmaceuticals (United States)(Current)

Eric J. Bonventre is an author at Cubist Pharmaceuticals (United States) specializing in antimicrobial resistance, drug resistance, and medicine.

Top concepts

Publications per year

2006–2008

3

Publications

3

In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in <i>Staphylococcus aureus</i>

Gregory T. Robertson, Eric J. Bonventre, Timothy B Doyle et al. · Antimicrobial Agents and Chemotherapy · 2008 · 67 citations · Full text

, , +22

In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci

Gregory T. Robertson, Eric J. Bonventre, Timothy B Doyle et al. · Antimicrobial Agents and Chemotherapy · 2008 · 59 citations · Full text

, , +14

New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases

Keith D. Combrink, Daniel A. Denton, Susan Harran et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 38 citations

, , +10

1–3 of 3